{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Ozempen.com","name":"Ozempen.com","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-10T15:32:34.477Z"},"count":1,"matches":[{"id":"ca2f02965dc37ebe","posted_date":"2024-07-02","letter_issue_date":"2024-06-24","company_name":"Ozempen.com","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet","canonical_url":"https://api.morvs.ai/fda-warning/ca2f02965dc37ebe"}]}